# Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

> clinical trial · VERIFIED · 2026-07-28

Status: RECRUITING · Sponsor: Neurotech Pharmaceuticals · Condition: Macular Telangiectasia Type 2 (MacTel)

- Company: Neurotech Pharmaceuticals
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT06971939

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.